Whether it’s a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get exclusive access to our free stock reports.
NuPathe, Inc. (NASDAQ: PATH) shares closed up 47.39 percent on Monday with about 10.6 million shares traded. The stock was one of the biggest gainers in the NASDAQ index. Endo Health Solutions announced it has entered into a definitive agreement under which Endo will acquire NuPathe Inc. for $2.85 per share in cash, or approximately $105 million. In addition to the upfront cash payment, NuPathe shareholders will receive rights to receive additional cash payments of up to $3.15 per share if specified net sales of NuPathe's migraine treatment ZECUITY are achieved over time.
Get more information on NuPathe, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/PATH
OncoSec Medical Incorporated (OTC: ONCS) shares closed up 9.50 percent on Monday with about 7 million shares traded. The stock hit a new 52-week high of $0.40 during intra-day trading and was one of the most actively traded stocks in the OTC market. The move came after the company announced positive interim data from its ongoing Phase 2 trial of OMS-I100 in the treatment of metastatic melanoma.
Get more information on OncoSec Medical Incorporated and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/ONCS
USEC Inc. (NYSE: USU) shares closed down 60.16 percent on Monday with about 3.8 million shares traded. The stock was one of the biggest decliners in the NYSE. USEC Inc, a supplier of enriched uranium for commercial nuclear power plants, said it expected to file for bankruptcy protection in the first quarter of 2014.
Get more information on USEC Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/USU
Nutranomics Inc. (OTCBB: NNRX) shares closed down 37.56 percent on Monday with about 5.1 million shares traded. The stock was one of the biggest decliners in the OTCBB market. On December 9, 2013, Nutranomics, Inc. entered into an equity purchase agreement with Southridge Partners II, LP, a Delaware limited partnership, whereby Southridge will purchase up to $10,000,000 of the Company's common stock, to be registered in a Form S-1 registration statement.
Get more information on Nutranomics Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/NNRX
Disclosure: TrendingWallStreet.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.
Leave a comment...